UK markets close in 4 hours 31 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2700+0.1200 (+5.58%)
At close: 04:00PM EST
2.3000 +0.03 (+1.32%)
Pre-market: 06:30AM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5272.24M
Enterprise value 3132.20M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)1.93
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-6.65

Trading information

Stock price history

Beta (5Y monthly) 2.04
52-week change 349.34%
S&P500 52-week change 324.47%
52-week high 39.8000
52-week low 30.8100
50-day moving average 32.8184
200-day moving average 33.3301

Share statistics

Avg vol (3-month) 34.26M
Avg vol (10-day) 33.2M
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8126.6M
% held by insiders 10.04%
% held by institutions 127.73%
Shares short (14 Nov 2021) 418.55M
Short ratio (14 Nov 2021) 45.48
Short % of float (14 Nov 2021) 414.65%
Short % of shares outstanding (14 Nov 2021) 414.65%
Shares short (prior month 14 Oct 2021) 420.97M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-16.12%
Return on equity (ttm)-30.76%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -19.89M
Net income avi to common (ttm)-27.76M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)140.04M
Total cash per share (mrq)1.11
Total debt (mrq)1.22k
Total debt/equity (mrq)0.00
Current ratio (mrq)85.32
Book value per share (mrq)1.11

Cash flow statement

Operating cash flow (ttm)-16.24M
Levered free cash flow (ttm)-8.74M